The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing superfunctional protein that can be further enhanced by CFTR modulators

Ten percent of cystic fibrosis (CF) patients carry a premature termination codon (PTC); no mutation-specific therapies exist for these individuals. ELX-02, a synthetic aminoglycoside, suppresses translation termination at PTCs (i.e., readthrough) by promoting the insertion of an amino acid at the PT...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianguo, Thrasher, Kari, Fu, Lianwu, Wang, Wei, Aghamohammadzadeh, Soheil, Wen, Hui, Tang, Liping, Keeling, Kim M., Falk Libby, Emily, Bedwell, David M., Rowe, Steven M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Physiological Society 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202470/
https://www.ncbi.nlm.nih.gov/pubmed/37014818
http://dx.doi.org/10.1152/ajplung.00038.2023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202470/
https://www.ncbi.nlm.nih.gov/pubmed/37014818
http://dx.doi.org/10.1152/ajplung.00038.2023

Ejemplares similares